Mylan Promises $300 Generic EpiPen

In a continuation of its response to widespread criticism, pharmaceutical company Mylan NV announced today that it will launch a generic version of the EpiPen at a 50% discount to the standard version of its popular allergy medication.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.